| Dr Laura Zuleme Delaplain, PHD | |
|
10 Bedford St, Abington, MA 02351 | |
| (781) 871-2051 | |
| (781) 871-5558 |
| Full Name | Dr Laura Zuleme Delaplain |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 35 Years |
| Location | 10 Bedford St, Abington, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427135599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 6086 (Massachusetts) | Primary |
| Entity Name | Institute For Spiritual Life And Psychotherapy Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528317583 PECOS PAC ID: 9830520014 Enrollment ID: O20200505000124 |
News Archive
New research has found that a child's relationships may be a hidden casualty long after a head injury. Neuroscientists at Brigham Young University studied a group of children three years after each had suffered a traumatic brain injury - most commonly from car accidents. The researchers found that lingering injury in a specific region of the brain predicted the health of the children's social lives.
AstraZeneca and Targacept, Inc. havey announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.
Savient Pharmaceuticals, Inc. announced a new publication showing that adult patients with refractory chronic gout (RCG) treated bi-weekly with KRYSTEXXA- (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain and physical function.
Ironwood Pharmaceuticals, Inc. today provided an update on its business activities for the second quarter of 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Zuleme Delaplain, PHD Po Box 2025, Abington, MA 02351 Ph: (781) 871-2051 | Dr Laura Zuleme Delaplain, PHD 10 Bedford St, Abington, MA 02351 Ph: (781) 871-2051 |
News Archive
New research has found that a child's relationships may be a hidden casualty long after a head injury. Neuroscientists at Brigham Young University studied a group of children three years after each had suffered a traumatic brain injury - most commonly from car accidents. The researchers found that lingering injury in a specific region of the brain predicted the health of the children's social lives.
AstraZeneca and Targacept, Inc. havey announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.
Savient Pharmaceuticals, Inc. announced a new publication showing that adult patients with refractory chronic gout (RCG) treated bi-weekly with KRYSTEXXA- (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain and physical function.
Ironwood Pharmaceuticals, Inc. today provided an update on its business activities for the second quarter of 2010.
› Verified 5 days ago